RxDoctor Payments Data

Antony Daros, DO

Family Medicine · Grand Blanc, MINPI 1003800350

Payments from drug & device makers

$5,878in general payments, 2019–2025

Across 325 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$599
  • AstraZeneca$543
  • Lilly USA, LLC$407
  • Boehringer Ingelheim$402
  • Biohaven Pharmaceuticals, Inc.$336
  • Novartis$330
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$5,59195%
  • Education$2875%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,878 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$58,994
Medicare patients
111
Services billed
1,019

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin81$96,839
MounjaroTirzepatide54$75,540
EliquisApixaban61$59,414
OzempicSemaglutide19$31,443
FarxigaDapagliflozin Propanediol19$30,852
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$14,965
Ezetimibe314$8,731
ProgesteroneProgesterone, Micronized87$6,127
Fentanyl59$4,981
Raloxifene Hcl79$4,513
Rosuvastatin Calcium208$4,491
Armour ThyroidThyroid,pork32$3,933
Losartan Potassium160$2,444
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen146$2,200
Tamsulosin Hcl60$1,666

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$402$96,83981 claims
Lilly USA, LLCMounjaro$407$75,54054 claims
PfizerEliquis$153$59,41461 claims
Novo NordiskOzempic$242$31,44319 claims
AstraZenecaFarxiga$543$30,85219 claims
GSKTrelegy Ellipta$212$14,96517 claims
AbbVieArmour Thyroid$243$3,93332 claims
Acella Pharmaceuticals, LLCNp Thyroid$143$1,54235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Grand Blanc

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →